Clinical Trial Update: GFM-Acadesine: A Phase I-II Trial of Acadesine [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating acadesine (GFM-Acadesine) for myelodysplastic syndromes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Acadesine

Snippet

Sponsor: Groupe Francophone des Myelodysplasies | Conditions: SMD | Phase 1, Phase 2 | Status: TERMINATED